Stem cell therapy is a putative treatment for end-stage heart failure. Bone marrow-derived mesenchymal stem cells (MSC) improve cardiac function following intramyocardial transplantation. Our previous study indicates that MSC preprogrammed to express GATA-4 (MSCGATA-4), a well-known cardiac transcription factor, significantly accelerate ischemic heart repair - by increasing MSC survival and differentiation, as well as angiogenesis. However, the mechanism is unclear. The recently discovered endogenous class of small non-coding RNAs, microRNAs (miRs), plays an important role in both cardiac protection and pathology associated with myocardial ischemia. Our preliminary data indicate that overexpression of GATA-4 in MSC modulates expression of several miRs which can then transfer from MSC into neighboring cardiomyocytes (CM). We propose the following two hypotheses: Hypothesis 1: Specific miRs and miR targeted genes mediate potent pro-survival and pro-angiogenic effects. Hypothesis 2: miRs in transplanted MSC transfer to neighboring host cells or the extracellular environment via gap junctions and microvesicles (MVs). The proposed study represents the first in- depth attempt to elucidate the mechanism by which GATA-4 overexpression in MSC regulates expression of specific miRs that, in turn, enhance angiogenesis and cardioprotection when these MSC are transplanted into ischemic myocardium. The results of these studies should (i) provide evidence that MSC besides their differentiation potential serve as an important delivery vehicle for cardioprotectve proteins and molecules in repair of ischemic myocardium;(ii) explore the impact of transfer of specific molecules from MSC to the extracellular fluid space via MVs, and directly into CM via gap junctions or other intercellular channels. These findings may not only highlight the molecular mechanisms of MSCGATA-4 - mediated angiogenesis, but may also help formulate a novel therapeutic strategy for ischemia and offer insight into the progression of myocardial remodeling.
Coronary artery disease is the most common cause of heart infarction. The cell-based therapy is a putative treatment for end-stage heart failure to use stem cells for regeneration and as vehicle for transfer of cardioprotective and regenerative small noncoding RNA to the host damaged cells for repair.
|Yu, Bin; Yang, Yueting; Liu, Huan et al. (2016) Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia Injury. PLoS One 11:e0151542|
|Okada, Motoi; Kim, Ha Won; Matsu-ura, Kaoru et al. (2016) Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase. Stem Cells 34:148-59|
|Cai, Wen-Feng; Kang, Kai; Huang, Wei et al. (2015) CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury. J Cell Mol Med 19:1825-35|
|Kang, Kai; Ma, Ruilian; Cai, Wenfeng et al. (2015) Exosomes Secreted from CXCR4 Overexpressing Mesenchymal Stem Cells Promote Cardioprotection via Akt Signaling Pathway following Myocardial Infarction. Stem Cells Int 2015:659890|
|Yu, Bin; Kim, Ha Won; Gong, Min et al. (2015) Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182:349-60|
|Liu, Honghai; Chen, Ruikai; Yang, Huaxiao et al. (2014) Enzyme-etching technique to fabricate micropatterns of aligned collagen fibrils. Biotechnol Lett 36:1245-52|
|Wang, Yuhua; Huang, Wei; Liang, Jialiang et al. (2014) Suicide gene-mediated sequencing ablation revealed the potential therapeutic mechanism of induced pluripotent stem cell-derived cardiovascular cell patch post-myocardial infarction. Antioxid Redox Signal 21:2177-91|
|Ma, Zhen; Liu, Qiuying; Yang, Huaxiao et al. (2013) Laser patterning for the study of MSC cardiogenic differentiation at the single-cell level. Light Sci Appl 2:|
|Gong, Min; Yu, Bin; Wang, Yi-Gang et al. (2013) Bone marrow rejuvenation. An excellent potential therapy for age-related endothelial dysfunction. Circ J 77:2886-8|
|Yu, Bin; Gong, Min; Wang, Yigang et al. (2013) Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles. PLoS One 8:e73304|
Showing the most recent 10 out of 11 publications